Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 22, 2012
A paradigm shift in drug development for treatment of rare multidrug-resistant gram-negative pathogens
Demissie Alemayehu, John Quinn, Jack Cook, et al.
AAPS Pharmscitech
|
November 13, 2013
Quality-by-design: are we there yet?
Jack Cook, Maria T Cruañes, Manish Gupta, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 2020
Response to "Personalized Dosing = Approved Wide Dose Ranges + Dose Titration"
J Robert Powell, Jack Cook, Yaning Wang, et al.
Clinical and Translational Science
|
September 21, 2020
The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin
Jack Cook, Milton L Pressler, Bharat Damle, et al.
Clinical and Translational Science
|
November 13, 2025
Representation of Older Adult Patients in Clinical Trials
Sebastian Haertter, Navita L Mallalieu, Soundos Saleh, et al.
Journal of Pharmaceutical Sciences
|
March 10, 2010
Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measure
Mohamed A Kamal, David E Smith, Jack Cook, et al.
Clinical Pharmacology in Drug Development
|
April 30, 2016
A randomized, open-label 3-way crossover study to investigate the relative bioavailability and bioequivalence of crushed sildenafil 20 mg tablets mixed with apple sauce, extemporaneously prepared suspension (EP), and intact sildenafil 20 mg tablets in healthy volunteers under fasting conditions
Xiang Gao, Marie-Noella Ndongo, Tina M Checchio, et al.
Journal of Clinical Pharmacology
|
June 26, 2015
A proposal for scientific framework enabling specific population drug dosing recommendations
Pravin R Jadhav, Jack Cook, Vikram Sinha, et al.
Clinical and Translational Science
|
November 17, 2021
To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias
Sebastian Haertter, Jitendar Kanodia, Jack Cook, et al.
Clinical Pharmacology and Therapeutics
|
July 21, 2020
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection
Melanie R Nicol, Abhay Joshi, Matthew L Rizk, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 22, 2012
A paradigm shift in drug development for treatment of rare multidrug-resistant gram-negative pathogens
Demissie Alemayehu, John Quinn, Jack Cook, et al.
AAPS Pharmscitech
|
November 13, 2013
Quality-by-design: are we there yet?
Jack Cook, Maria T Cruañes, Manish Gupta, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 2020
Response to "Personalized Dosing = Approved Wide Dose Ranges + Dose Titration"
J Robert Powell, Jack Cook, Yaning Wang, et al.
Clinical and Translational Science
|
September 21, 2020
The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin
Jack Cook, Milton L Pressler, Bharat Damle, et al.
Clinical and Translational Science
|
November 13, 2025
Representation of Older Adult Patients in Clinical Trials
Sebastian Haertter, Navita L Mallalieu, Soundos Saleh, et al.
Journal of Pharmaceutical Sciences
|
March 10, 2010
Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measure
Mohamed A Kamal, David E Smith, Jack Cook, et al.
Clinical Pharmacology in Drug Development
|
April 30, 2016
A randomized, open-label 3-way crossover study to investigate the relative bioavailability and bioequivalence of crushed sildenafil 20 mg tablets mixed with apple sauce, extemporaneously prepared suspension (EP), and intact sildenafil 20 mg tablets in healthy volunteers under fasting conditions
Xiang Gao, Marie-Noella Ndongo, Tina M Checchio, et al.
Journal of Clinical Pharmacology
|
June 26, 2015
A proposal for scientific framework enabling specific population drug dosing recommendations
Pravin R Jadhav, Jack Cook, Vikram Sinha, et al.
Clinical and Translational Science
|
November 17, 2021
To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias
Sebastian Haertter, Jitendar Kanodia, Jack Cook, et al.
Clinical Pharmacology and Therapeutics
|
July 21, 2020
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection
Melanie R Nicol, Abhay Joshi, Matthew L Rizk, et al.
Page
of 3